Tesamoreline – 10mg
B's Research Labs | Research Overview
B's Research Labs Tesamorelin is a synthetic 44-amino-acid analogue of growth hormone–releasing hormone (GHRH). Its molecular structure incorporates a trans-3-hexenoyl modification at the N-terminal tyrosine residue, contributing to its distinctive biochemical characteristics and peptide stability. This structural modification distinguishes Tesamorelin from naturally occurring GHRH and makes it a compound of interest in peptide chemistry, molecular biology, receptor-binding studies, and biochemical research involving growth hormone–releasing hormone signaling pathways.
Supplied in a 10 mg lyophilized powder format, Tesamorelin is intended exclusively for controlled laboratory research and analytical applications. Laboratory investigations may focus on peptide stability, molecular structure, receptor-binding characteristics, biochemical interactions, and compound behavior under controlled experimental conditions. Research involving Tesamorelin may also examine GHRH receptor activation, growth hormone-related molecular signaling, endocrine regulatory pathways, and biochemical processes associated with lipid metabolism. These investigations do not establish the safety, efficacy, or suitability of this research product for clinical applications.
RUO — RESEARCH USE ONLY
For in vitro laboratory research and analytical applications only.
NOT FOR HUMAN OR VETERINARY USE. NOT FOR CONSUMPTION, INJECTION, INGESTION, OR CLINICAL ADMINISTRATION.
Not intended for diagnostic, therapeutic, pharmaceutical, cosmetic, or personal use. No claims are made regarding safety, efficacy, or suitability for human or animal applications.
Compound Identification
Tesamorelin is a synthetic 44-amino-acid GHRH analogue containing an N-terminal trans-3-hexenoyl modification, investigated in molecular and biochemical research involving GHRH receptor interactions and endocrine signaling pathways.
